{"id":14275,"date":"2021-06-02T09:04:01","date_gmt":"2021-06-02T07:04:01","guid":{"rendered":"https:\/\/ggba.swiss\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/"},"modified":"2023-07-04T13:40:17","modified_gmt":"2023-07-04T11:40:17","slug":"eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/","title":{"rendered":"Eye diseases detection specialist EarlySight secures CHF 2.3 million"},"content":{"rendered":"<p>Founded in 2019,\u00a0<a href=\"https:\/\/www.earlysight.com\/\" target=\"_blank\" rel=\"noopener\">EarlySight<\/a>\u00a0uses a novel approach to provide a single cell level imaging of the back of the eye, called the retina. Its technology combines hardware and software to propose a unique medical device that can observe the cells affected at the early stage of the most prevalent retinal diseases such as age-related macular degeneration, glaucoma or diabetic retinopathy, to treat them sooner and\u00a0more efficiently.<\/p>\n<p>The <a href=\"https:\/\/www.epfl.ch\/en\/\" target=\"_blank\" rel=\"noopener\">EPFL<\/a> spin-off has announced the closing of CHF 2.3 million out of a CHF 3 million seed funding round led by\u00a0<a href=\"https:\/\/www.verve.vc\/\" target=\"_blank\" rel=\"noopener\">Verve Ventures<\/a>\u00a0with participation from\u00a0<a href=\"https:\/\/www.nina.capital\/\" target=\"_blank\" rel=\"noopener\">Nina Capital<\/a>, a European early-stage health tech fund and other private\u00a0investors\u00a0that\u00a0followed a pre-seed investment.<\/p>\n<p>\u201cThe need for deeper understanding and earlier diagnosis of retinal diseases is only going to increase with the current trends of an ageing population. Earlysight has the right ingredients to address this need\u201d, said Sebastian Anastassiou of Nina Capital.<\/p>\n<p>The secured CHF 2.3 million will allow EarlySight to grow its team, optimize its technology and perform further clinical\u00a0validations.\u00a0In addition, the start-up plans to reach\u00a0important milestones\u00a0as it\u00a0prepares\u00a0for market entry.<\/p>\n<p>\u201cEarlySight is also very relevant for pharmaceutical development, as the lack of objective clinical endpoints has made the development of early treatment difficult. Overall, EarlySight really has the potential to be the next breakthrough technology in retinal imaging, in the same way, that OCT was 20 years ago\u201d, says Susanne Schorsch, Investment Manager at Verve Ventures.<\/p>\n<p>The Vaud-based company\u2019s seed round remains open until July for a second closing with an additional CHF 600&#8217;000 investment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EPFL spin-off EarlySight has secured CHF 2.3 million for the development of\u00a0a medical device that helps doctors detect and treat eye diseases at an early stage.<\/p>\n","protected":false},"author":3,"featured_media":14276,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[963,898,902],"class_list":["post-14275","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-medical-devices","tag-optics","tag-personalized-medicine"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eye diseases detection specialist EarlySight secures CHF 2.3 million - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eye diseases detection specialist EarlySight secures CHF 2.3 million - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"EPFL spin-off EarlySight has secured CHF 2.3 million for the development of\u00a0a medical device that helps doctors detect and treat eye diseases at an early stage.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-02T07:04:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:40:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-4.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Eye diseases detection specialist EarlySight secures CHF 2.3 million\",\"datePublished\":\"2021-06-02T07:04:01+00:00\",\"dateModified\":\"2023-07-04T11:40:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/\"},\"wordCount\":264,\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-4.jpeg\",\"keywords\":[\"Medical Devices\",\"Optics\",\"Personalized Medicine\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/\",\"name\":\"Eye diseases detection specialist EarlySight secures CHF 2.3 million - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-4.jpeg\",\"datePublished\":\"2021-06-02T07:04:01+00:00\",\"dateModified\":\"2023-07-04T11:40:17+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-4.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-4.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eye diseases detection specialist EarlySight secures CHF 2.3 million\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eye diseases detection specialist EarlySight secures CHF 2.3 million - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/","og_locale":"en_US","og_type":"article","og_title":"Eye diseases detection specialist EarlySight secures CHF 2.3 million - Greater Geneva Bern area","og_description":"EPFL spin-off EarlySight has secured CHF 2.3 million for the development of\u00a0a medical device that helps doctors detect and treat eye diseases at an early stage.","og_url":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2021-06-02T07:04:01+00:00","article_modified_time":"2023-07-04T11:40:17+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-4.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mathieu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#article","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Eye diseases detection specialist EarlySight secures CHF 2.3 million","datePublished":"2021-06-02T07:04:01+00:00","dateModified":"2023-07-04T11:40:17+00:00","mainEntityOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/"},"wordCount":264,"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-4.jpeg","keywords":["Medical Devices","Optics","Personalized Medicine"],"articleSection":["Life sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/","url":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/","name":"Eye diseases detection specialist EarlySight secures CHF 2.3 million - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#primaryimage"},"image":{"@id":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-4.jpeg","datePublished":"2021-06-02T07:04:01+00:00","dateModified":"2023-07-04T11:40:17+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-4.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Eye-Disease-Retina-630x380-4.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/staging.ggba.swiss\/en\/eye-diseases-detection-specialist-earlysight-secures-chf-2-3-million\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"Eye diseases detection specialist EarlySight secures CHF 2.3 million"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/en\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=14275"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14275\/revisions"}],"predecessor-version":[{"id":16944,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/14275\/revisions\/16944"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/14276"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=14275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=14275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=14275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}